Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tozivepi Aaron Munyayi has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Inertness of the Lysozyme Template: Assessing the Structural Impact of Silicification Byproducts and Precursors

    by Tozivepi Aaron Munyayi, Francesco Bruno, Letizia Fiorucci, Vincenzo Mangini, Francesco Scattarella, Cinzia Giannini, Jose Malanho Da Silva, Giacomo Parigi, Angelo Gallo, Enrico Ravera

    Bioinspired silica deposition with biomolecular templates offers a sustainable route to producing advanced inorganic materials. The templating agent is usually a polycation. Recent experimental evidence links the templating capability of polycationic polymers to self‐assembly, coacervation, or liquid–liquid phase separation processes that precede silica deposition. However, when a polycationic protein is used, there is no evidence of liquid–liquid phase separation and the behavior of folded proteins during the hydrolysis of silicon alkoxides (TMOS/TEOS) remains poorly understood. In this study, we investigate the stability and dispersity of lysozyme in the presence of the alkoxide hydrolysis byproducts (methanol and ethanol) and a nonreactive tetrahedral mimic of orthosilicic acid (pentaerythritol). Using Small‐Angle X‐ray Scattering (SAXS) and Nuclear Magnetic Resonance (NMR) spectroscopy, we demonstrate that lysozyme retains its fold and monomeric state in the presence of these species, with no evidence of aggregation or unfolding. Furthermore, we show that unlike disordered peptides, lysozyme does not require anions for structural organization, even if some self‐interaction in the presence of phosphate or other anions is found to occur. These findings support the previously proposed mechanistic model in which the folded protein provides a robust, preorganized electrostatic scaffold for silica deposition, independent of solvent‐induced phase transitions.

  • Open Access

    Anisotropic Gold Nanostars Functionalized with 2-Thiouracil: A Multifunctional Platform for Colorimetric Biosensing and Photothermal Cancer Therapy

    by Tozivepi Aaron Munyayi, Anine Crous, Heidi Abrahamse

    This study presents a multifunctional theranostic platform based on anisotropic gold nanostars (AuNSs) functionalized with 2-thiouracil (2-TU) for cancer diagnostics and photothermal therapy (PTT). The unique plasmonic properties of AuNSs, combined with the anticancer and photothermal potential of 2-TU, were harnessed to create a system capable of simultaneous colorimetric biosensing and therapeutic action. Under dual-wavelength irradiation (660 nm and 525 nm), the AuNSs–2-TU conjugate demonstrated enhanced photothermal conversion efficiency, selective cancer cell targeting, and signal amplification, resulting in a significant reduction in the IC50 for MCF-7 breast cancer cells. The system exhibited minimal cytotoxicity to normal fibroblasts (WS1), ensuring therapeutic precision. Compared to conventional spherical gold nanoparticles, this platform provides superior multifunctionality, including real-time biosensing with simple, naked-eye colorimetric readouts. These results highlight the potential of the AuNSs–2-TU conjugate as an innovative, minimally invasive nanotheranostic platform suitable for integrated cancer detection and treatment, particularly in resource-constrained settings.


  • Open Access

    Advancing Cancer Drug Delivery with Nanoparticles: Challenges and Prospects in Mathematical Modeling for In Vivo and In Vitro Systems

    by Tozivepi Aaron Munyayi, Anine Crous

    Mathematical models are crucial for predicting the behavior of drug conjugate nanoparticles and optimizing drug delivery systems in cancer therapy. These models simulate interactions among nanoparticle properties, tumor characteristics, and physiological conditions, including drug resistance and targeting specificity. However, they often rely on assumptions that may not accurately reflect in vivo conditions. In vitro studies, while useful, may not fully capture the complexities of the in vivo environment, leading to an overestimation of nanoparticle-based therapy effectiveness. Advancements in mathematical modeling, supported by preclinical data and artificial intelligence, are vital for refining nanoparticle-based therapies and improving their translation into effective clinical treatments.


  • Open Access

    Quantitative Galactose Colorimetric Competitive Assay Based on Galactose Dehydrogenase and Plasmonic Gold Nanostars

    by Tozivepi Aaron Munyayi, Danielle Wingrove Mulder, Engela Helena Conradie, Frans Johannes Smit, Barend Christiaan Vorster

    We describe a competitive colorimetric assay that enables rapid and sensitive detection of galactose and reduced nicotinamide adenine dinucleotide (NADH) via colorimetric readouts and demonstrate its usefulness for monitoring NAD+-driven enzymatic reactions. We present a sensitive plasmonic sensing approach for assessing galactose concentration and the presence of NADH using galactose dehydrogenase-immobilized gold nanostars (AuNS-PVP-GalDH). The AuNS-PVP-GalDH assay remains turquoise blue in the absence of galactose and NADH; however, as galactose and NADH concentrations grow, the reaction well color changes to a characteristic red color in the presence of an alkaline environment and a metal ion catalyst (detection solution). As a result, when galactose is sensed in the presence of H2O2, the colored response of the AuNS-PVP-GalDH assay transforms from turquoise blue to light pink, and then to wine red in a concentration-dependent manner discernible to the human eye. This competitive AuNS-PVP-GalDH assay could be a viable analytical tool for rapid and convenient galactose quantification in resource-limited areas.


  • Open Access

    Feasibility of NAD(P)/NAD(P)H as redox agents in enzymatic plasmonic gold nanostar assays for galactose quantification

    by Tozivepi Aaron Munyayi, Danielle Wingrove Mulder, Engela Helena Conradie, Barend Christiaan Vorster

    Plasmonic colorimetric sensors have emerged as powerful analytical tools in biochemistry due to their localized surface plasmon resonance extinction in the visible range. Here, we describe the feasibility of NAD(P)/NAD(P)H as redox agents in enzymatic plasmonic gold nanostar (AuNS) assays for galactose quantification using three model enzymes, GalDH, AR and GalOx, immobilized separately on polyvinylpyrrolidone-capped AuNS scaffolds. These highly specific, sensitive and selective bioassays induce the transformation of AuNS into quasi-spherical nanoparticles during the biorecognition of galactose in water and synthetic blood matrices. As a result, using our inexpensive and simple AuNS plasmon bioassays, the presence of galactose may be detected spectrophotometrically and by the naked eye.


  • Open Access

    Quantitative Galactose Colorimetric Competitive Assay Based on Galactose Dehydrogenase and Plasmonic Gold Nanostars

    by Tozivepi Aaron Munyayi, Danielle Wingrove Mulder, Engela Helena Conradie, Barend Christiaan Vorster

    We describe a competitive colorimetric assay that enables rapid and sensitive detection of galactose and reduced nicotinamide adenine dinucleotide (NADH) via colorimetric readouts and demon-strates its usefulness for monitoring NAD+-driven enzymatic reactions. We present a sensitive plasmonic sensing approach for assessing galactose concentration and the presence of NADH using galactose dehydrogenase immobilized gold nanostars (AuNS-PVP-GalDH). The AuNS-PVP-GalDH assay remains turquoise blue in the absence of galactose and NADH; however, as galactose and NADH concentrations grow, the reaction well color changes to a characteristic red color in the presence of an alkaline environment and metal ions catalyst (detection solution). As a result, when galactose is sensed in the presence of H2O2, the colored response of the AuNS-PVP-GalDH assay transforms from turquoise blue to light pink, then to wine red in a con-centration-dependent manner discernible to the human eye. This competitive AuNS-PVP-GalDH assay could be a viable analytical tool for rapid and convenient galactose quantification in re-source-limited areas.

  • Open Access

    The Effect of Capping Agents on Gold Nanostar Stability, Functionalization, and Colorimetric Biosensing Capability

    by Tozivepi Aaron Munyayi, Barend Christiaan Vorster, Danielle Wingrove Mulder

    Capping agents (organic ligands, polymers, and surfactants) are pivotal for stabilizing nanoparticles; however, they may influence the surface chemistry, as well as the physico-chemical and biological characteristics, of gold nanostar (AuNS)-based biosensors. In this study, we proved that various capping agents affected capped and bioconjugated AuNS stability, functionality, biocatalysis, and colorimetric readouts. Capped and bioconjugated AuNSs were applied as localized surface plasmon resonance (LSPR)-based H2O2 sensors using glucose oxidase (GOx) as a model enzyme. Furthermore, our analyses revealed that the choice of capping agent influenced the properties of the AuNSs, their stability, and their downstream applications. Our analyses provide new insights into factors governing the choice of capping agents for gold nanostars and their influences on downstream applications with conjugated enzymes in confined environments.